Genetic risk refers to how inherited DNA differences influence the likelihood of developing diseases, especially complex conditions like heart disease, diabetes or cancer. Instead of a single mutation causing illness, many common diseases arise from hundreds or thousands of genetic variants, each with small effects that add up.

Researchers now use large genome wide association studies to scan the DNA of hundreds of thousands of people, linking specific variants to disease outcomes. From these data, they build polygenic risk scores that sum the effects of many variants into a single number estimating an individual’s inherited susceptibility. People in the highest risk groups can have several fold higher chances of developing certain conditions compared with the average person.

Genetic risk is not destiny. Environment and lifestyle factors such as diet, smoking, activity and pollution can either amplify or buffer inherited risk. In some cases, healthy behavior can reduce overall risk to near average levels even for those with high genetic risk. Researchers therefore emphasize combining genetic information with clinical and lifestyle data to guide prevention and treatment.

There are important limitations. Most genetic studies so far have focused on people of European ancestry, which reduces accuracy in other populations and risks widening health inequalities. Polygenic scores also capture statistical associations, not direct causality, and their predictive power varies strongly between diseases.

Future work aims to make genetic risk assessment more accurate, equitable and clinically useful. This includes diversifying study populations, improving statistical models and carefully evaluating how using genetic information affects medical decisions and patient outcomes.